ÂÜÀòÂÒÂ×

Sandra (Sandee) Sutera is an experienced professional in the pharmaceutical and biotechnology industries, currently serving as Vice President and Head of Program & Portfolio Management, as well as Chief of Staff to the President of Research and Development at Tango Therapeutics. Prior to this role, Sandra held several senior director positions at Moderna, including Head of Operations and Head of Program Management, along with leadership in Infectious Disease Program Management. Earlier career experiences at Eli Lilly and Company encompassed roles such as Team Leader in Pharmaceutical Project Management and Project Manager in Oncology. Sandra possesses a Bachelor of Science in Biochemistry from the University of Minnesota.